The Human Immunodeficiency Virus, (HIV-1), pandemic: Cellular therapies, stem cells and biobanking

作者：Stephens Linda Lee; Swanepoel Carmen Catherine Ann; Van Rooyen Beverley Ann; Abayomi Emmanuel Akinola^*

来源：Transfusion and Apheresis Science, 2013, 49(1): 9-11.

DOI：10.1016/j.transci.2013.05.017

• Human Immunodeficiency Virus
• Cellular therapies
• Stem cells
• Biobanking

The Human Immunodeficiency Virus, (HIV-1), has become a major global health threat with recent estimates suggesting that 68% of people living with HIV (PLWH) reside in Sub-Saharan Africa. The current strategies for containment of this disease in the absence of an effective vaccine are of concern in terms of long-term fiscal sustainability and cost effectiveness.
HIV prevalence rates are set to rise, not because of increasing incidence but rather because of the effort involved in implementing the anti-retroviral (ARV) programmes, especially on the African continent. Even when sub-optimally delivered, these therapies will lead to a decrease in mortality rates and prevent early death from opportunistic infections. However, evidence is emerging for long-term systemic effects of chronic HIV infection in persons on ARV therapy, including increased incidence of Haematological abnormalities and malignancies.

• 出版日期2013-8